Cytokinetics
CYTK
50.78
-0.68
-1.32%
Cytokinetics
US · CYTK
#1564 by market cap
Listed 1970
50.78
-0.68
-1.32%
Periodic snapshot; not a real-time feed.
· 2026-11-20 20:02
Recent news
-
Rating change
RBC Capital Maintains Cytokinetics(CYTK.US) With Buy Rating, Maintains Target Price $113Market Newswire · 2026/10/15
-
Rating change
Wells Fargo Maintains Cytokinetics(CYTK.US) With Buy Rating, Maintains Target Price $105Market Newswire · 2026/10/4
-
Rating change
Barclays Maintains Cytokinetics(CYTK.US) With Buy Rating, Maintains Target Price $110Market Newswire · 2026/8/27
-
A Quick Look at Today's Ratings for Cytokinetics(CYTK.US), With a Forecast Between $78 to $140Market Newswire · 2026/11/5
-
Rating change
Analysts' Opinions Are Mixed on These Healthcare Stocks: Regeneron (REGN), Cytokinetics (CYTK) and Biohaven Ltd. (BHVN)TipRanks · 2026/9/10
-
Rating change
Morgan Stanley Maintains Cytokinetics(CYTK.US) With Buy Rating, Maintains Target Price $103Market Newswire · 2026/11/3
-
Rating change
A Quick Look at Today's Ratings for Cytokinetics(CYTK.US), With a Forecast Between $85 to $140Market Newswire · 2026/9/1
-
Rating change
RBC Capital Maintains Cytokinetics(CYTK.US) With Buy Rating, Maintains Target Price $112Market Newswire · 2026/9/10
-
Rating change
J.P. Morgan Maintains Cytokinetics(CYTK.US) With Buy RatingMarket Newswire · 2026/10/14
-
Rating change
UBS Maintains Cytokinetics(CYTK.US) With Buy Rating, Maintains Target Price $104Market Newswire · 2026/10/15
-
Rating change
UBS Maintains Cytokinetics(CYTK.US) With Buy Rating, Cuts Target Price to $104Market Newswire · 2026/10/14
-
Rating change
BofA Securities Maintains Cytokinetics(CYTK.US) With Hold Rating, Maintains Target Price $85Market Newswire · 2026/8/31
-
Rating change
BofA Securities Maintains Cytokinetics(CYTK.US) With Hold Rating, Cuts Target Price to $81Market Newswire · 2026/10/19
-
Rating change
RBC Capital Maintains Cytokinetics(CYTK.US) With Buy Rating, Raises Target Price to $113Market Newswire · 2026/10/8
-
A Quick Look at Today's Ratings for Cytokinetics(CYTK.US), With a Forecast Between $100 to $140Market Newswire · 2026/11/6
-
Rating change
Needham Maintains Cytokinetics(CYTK.US) With Buy Rating, Maintains Target Price $112Market Newswire · 2026/10/5
-
Rating change
Barclays Maintains Cytokinetics(CYTK.US) With Buy Rating, Raises Target Price to $110Market Newswire · 2026/8/14
-
Truist Financial Maintains Cytokinetics(CYTK.US) With Buy Rating, Maintains Target Price $112Market Newswire · 2026/11/6
-
H.C. Wainwright Maintains Cytokinetics(CYTK.US) With Buy Rating, Maintains Target Price $140Market Newswire · 2026/11/9
-
Citi Maintains Cytokinetics(CYTK.US) With Buy Rating, Maintains Target Price $105Market Newswire · 2026/11/7
-
Rating change
Truist Financial Maintains Cytokinetics(CYTK.US) With Buy Rating, Maintains Target Price $112Market Newswire · 2026/9/2
-
Rating change
Truist Financial Maintains Cytokinetics(CYTK.US) With Buy Rating, Announces Target Price $112Market Newswire · 2026/8/13
-
Rating change
J.P. Morgan Maintains Cytokinetics(CYTK.US) With Buy Rating, Maintains Target Price $103Market Newswire · 2026/8/13
-
Rating change
A Quick Look at Today's Ratings for Cytokinetics(CYTK.US), With a Forecast Between $100 to $140Market Newswire · 2026/8/8
-
H.C. Wainwright Maintains Cytokinetics(CYTK.US) With Buy Rating, Maintains Target Price $140Market Newswire · 2026/10/20
Headlines are aggregated automatically and are not independently verified or edited by our team.
Quote time 2026-11-20 20:02:43 · For reference only, not investment advice and not tailored to your situation.
Cytokinetics discussion 0 comments